Existing sample-to-result analyzers cost >$10K. Sparrow has lowered manufacturing costs by up to 50X.





First point-of-care pharmacogenetic test. Two FDA 510(k) clearances.
First point-of-care allergy testing platform. FDA 510(k) clearance and CLIA Waiver.
First DNA self-collection kit. Co-invented 8 patents.

